Harout Semerjian

2023

In 2023, Harout Semerjian earned a total compensation of $2.4M as President and Chief Executive Officer at GlycoMimetics, a 67% increase compared to previous year.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$376,910
Option Awards$1,263,328
Salary$638,405
Other$10,775
Total$2,389,418

Semerjian received $1.3M in option awards, accounting for 53% of the total pay in 2023.

Semerjian also received $100K in bonus, $376.9K in non-equity incentive plan, $638.4K in salary and $10.8K in other compensation.

Rankings

In 2023, Harout Semerjian's compensation ranked 426th out of 2,983 executives tracked by ExecPay. In other words, Semerjian earned more than 85.7% of executives.

ClassificationRankingPercentile
All
426
out of 2,983
86th
Division
Manufacturing
241
out of 1,637
85th
Major group
Chemicals And Allied Products
170
out of 906
81st
Industry group
Drugs
167
out of 869
81st
Industry
Pharmaceutical Preparations
105
out of 627
83rd
Source: SEC filing on April 1, 2024.

Semerjian's colleagues

We found two more compensation records of executives who worked with Harout Semerjian at GlycoMimetics in 2023.

2023

Brian Hahn

GlycoMimetics

Chief Financial Officer

2023

Edwin Rock

GlycoMimetics

Chief Medical Officer

News

In-depth

You may also like